Test Laboratories Sample Clauses

Test Laboratories. The Test Laboratories agree to run three lab-financed Sequence VID tests on each Matrix test stand to ensure proper test calibration. The Matrix requires two stands at each Test Laboratory. These test stands will be considered calibrated upon the successful completion of the Sequence VID Test Matrix and in compliance with calibration criteria as determined by the Sequence VI Surveillance Panel. The calibration period will begin concurrently with the effective date of ACC registration of the VID. To maintain confidentiality of pricing information, the full and final prices paid to a Matrix Lab are shown only on that Matrix Lab’s copy of this MOA and the master copy kept by API.  Intertek Automotive Research will provide to ASTM, at no charge, the pertinent data and results of 6 tests for the Sequence VID matrix. Intertek also commits to conduct 16 tests for the Sequence VID matrix at the fixed full and final price of  Southwest Research Institute will provide to ASTM, at no charge, the pertinent data and results of 6 tests for the Sequence VID matrix. Southwest Research Institute also commits to conduct 16 tests for the Sequence VID matrix at the fixed full and final price of . All tests submitted by the Test Laboratories must be operationally valid. Operational validity of engine tests will be determined by the testing laboratory using guidance from the ASTM TMC and input from the Project Supervisor using guidelines established by the ASTM Sequence VI Surveillance Panel prior to the start of the matrix. Matrix tests that are determined to be operationally invalid will be re-run at the test laboratory’s expense. The Test Laboratories are not responsible for performing any testing beyond what is stated above. Sequence VID testing will begin when the test has been formally affirmed "ready for Matrix testing" by the PCEOCP and all other conditions set forth in Scope have been met. Testing shall be conducted in accordance with the approved Test Matrix (see Attachment). The targeted completion date for the Sequence VID Test Matrix is three (3) months after its commencement date. The stands included in the Test Matrix should be used exclusively for matrix testing until the assigned tests in those stands have been completed. The commencement date is the date that the first Matrix test begins. Extension of the timing past this targeted completion date must be approved by the ILSAC/Oil Committee.
AutoNDA by SimpleDocs
Test Laboratories. Each Party shall notify the other of the test laboratories designated to carry out the tests pertaining to the procedures referred to in Article 10 of Directive 98/13/EC. The criteria fixed by the relevant harmonised standards for the designation of such laboratories shall be applied.
Test Laboratories. The Test Laboratories agree to provide the following resources to ASTM for use in the PC-10 Test Matrix. Caterpillar C13 Cummins ISB Xxxx T-12 Lab Lab Financed Runs ACC/API/EMA Financed Runs Lab Financed Runs ACC/API/EMA Financed Runs Lab Financed Runs ACC/API/EMA Financed Runs SwRI To maintain confidentiality of pricing information, the full and final prices paid to a lab are shown only on that lab’s copy and the master copy kept by API. • PerkinElmer will provide to ASTM, at no charge, the pertinent data and results of ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx T-12 tests for the PC-10 matrix. PerkinElmer also commits to conduct ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx X-12 tests for the PC-10 matrix at the full and final price of • Southwest Research Institute will provide to ASTM, at no charge, the pertinent data and results of ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx T-12 tests for the PC-10 matrix. Southwest Research also commits to conduct ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx X-12 tests for the PC-10 matrix at the full and final price of . All tests submitted by the Test Laboratories must be operationally valid. Operational validity of engine tests will be determined by the testing laboratory using guidance from the ASTM Test Monitoring Center (hereinafter the "ASTM TMC") and input from the Project Manager using guidelines established by appropriate ASTM Surveillance Panels prior to the start of each matrix. Matrix tests that are determined to be operationally invalid will be re-run at the cost of the test laboratory. The Test Laboratories are not responsible for performing any testing beyond what is stated above. ASTM and the appropriate ASTM committees agree to act as the fund and test administrators for the PC-10 matrix. The responsibilities of ASTM and the ASTM committees are as follows: • ASTM will act as the fund-dispersing agency for the PC-10 matrix. API, ACC, and EMA will be invoiced as described above in Agreement Concerning Funding and Resources, section (a), second paragraph, according to the contribution level of each association. ASTM will disburse funds to the Test Laboratories on a per test basis. • ASTM HDEOCP will be responsible for the management of the PC-10 matrix testing. The PC-10 New Category Development Team (hereinafter the “PC-10 NCDT”) and API/EMA Diesel Engine Oil Advisory Panel (hereinafter the “DEOAP”) will provide oversight and guidance to the ASTM HDEO...

Related to Test Laboratories

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Laboratory Services Covered Services include prescribed diagnostic clinical and anatomic pathological laboratory services and materials when authorized by a Member's PCP and HPN’s Managed Care Program.

  • Technology Research Analyst Job# 1810 General Characteristics

  • Radiation Therapy/Chemotherapy Services This plan covers chemotherapy and radiation services. This plan covers respiratory therapy services. When respiratory services are provided in your home, as part of a home care program, durable medical equipment, supplies, and oxygen are covered as a durable medical equipment service.

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • COVID-19 Vaccine Passports Pursuant to Texas Health and Safety Code, Section 161.0085(c), Contractor certifies that it does not require its customers to provide any documentation certifying the customer’s COVID-19 vaccination or post-transmission recovery on entry to, to gain access to, or to receive service from the Contractor’s business. Contractor acknowledges that such a vaccine or recovery requirement would make Contractor ineligible for a state-funded contract.

  • Salary Packaging (1) For the purposes of this Agreement, salary packaging shall mean an arrangement whereby the wage or salary benefit arising under a contract of employment is reduced, with another or other benefits to the value of the replaced salary being substituted and due to the practitioner. (2) A practitioner may, by agreement with the employer, enter into a salary packaging arrangement. (3) The employer shall not unreasonably withhold agreement to salary packaging on request from a practitioner. (4) The employer shall not require a practitioner to enter into a salary packaging arrangement, provided that this clause will not impinge on any additional employer provided benefits. (5) A salary packaging arrangement shall be formulated and operate on the basis that, on balance, there shall be no material disadvantage to the practitioner concerned, and shall be cost neutral in relation to the total employment cost to the employer. (6) A salary packaging arrangement must comply with relevant taxation laws and the employer shall not be liable for additional tax, penalties or other costs payable or which may become payable by the practitioner. (7) In the event of any increase or additional payments of tax or penalties associated with the employment of the practitioner, or the provision of employer benefits under the salary packaging agreement, such tax, penalties and any other costs shall be borne by the practitioner. (8) A practitioner may elect to cancel any salary packaging arrangement by giving a minimum of four weeks notice. (9) The employer may elect to cancel any salary packaging arrangement by giving a minimum of four weeks notice if the employer incurs a liability to pay fringe benefits tax or any other tax in respect of the non-cash benefits provided, provided that the employer cannot retrospectively cancel any salary packaging arrangement. (10) Notwithstanding subclauses (8) and (9) of this clause, the employer and the Practitioner may agree to forgo the notice period. (11) The cancellation of salary packaging will not cancel or otherwise effect the operation of this Agreement. (12) For the purposes of this provision, any penalty rate, loading or other salary related allowances which would ordinarily be calculated on the basis of the salary rates expressed in Schedule 1 Full Time Annual Base Salary Rates shall continue to be so calculated despite an election to participate in any salary packaging arrangement. (13) For the purposes of this provision, statutory 9% employer superannuation contributions shall be made on the basis of pre-packaging salary rates. To avoid doubt, employer contributions shall not be reduced as a result of a practitioner participating in salary packaging pursuant to this provision. (14) The employer may at any time vary the range of benefits provided or the conditions under which benefits are provided however the employer shall not differentiate between different class of practitioners across WA Health in terms or range of benefits or the conditions under which benefits are provided. (15) If a practitioner is found to have committed misconduct in the claiming a salary packaging benefit the employer is entitled to prospectively cease to provide some or all salary packing benefits either indefinitely or for any period determined by the employer.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!